Barclays PLC Centogene N.V. Transaction History
Barclays PLC
- $288 Billion
- Q1 2024
A detailed history of Barclays PLC transactions in Centogene N.V. stock. As of the latest transaction made, Barclays PLC holds 15,348 shares of CNTG stock, worth $5,832. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,348
Previous 15,348
-0.0%
Holding current value
$5,832
Previous $18,000
38.89%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CNTG
# of Institutions
16Shares Held
2.14MCall Options Held
0Put Options Held
0-
Platinum Investment Management LTD Sydney Australia 2000, C31.19MShares$450,7180.03% of portfolio
-
Scoggin Management LP New York, NY532KShares$201,9960.15% of portfolio
-
Wells Fargo & Company San Francisco, CA197KShares$74,9170.0% of portfolio
-
Landscape Capital Management, L.L.C.120KShares$45,5620.01% of portfolio
-
Stifel Financial Corp St. Louis, MO22.5KShares$8,5310.0% of portfolio
About Centogene N.V.
- Ticker CNTG
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,081,600
- Market Cap $10.3M
- Description
- Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...